Table 2 Correlation between clinicopathological status and expression of tRF-3013b
From: tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L
Variable | Category | Relative tRF-3013b expression | χ2 | P | |
|---|---|---|---|---|---|
Low (n = 18) | High (n = 19) | ||||
Age (years) | < 60 | 6 | 8 | 0.302 | 0.737 |
≥ 60 | 12 | 11 |  |  | |
Gender | Male | 6 | 5 | 0.218 | 0.728 |
Female | 12 | 14 | Â | Â | |
Histological differentiation | Poor | 8 | 13 | 0.650 | 0.508 |
Moderate or well | 10 | 6 | Â | Â | |
T stage | Tis-T2 | 4 | 9 | 2.565 | 0.170 |
T3–T4 | 14 | 10 |  |  | |
Lymph node metastasis | Present | 13 | 8 | 3.416 | 0.099 |
Absent | 5 | 11 | Â | Â | |